J Tollemar
Hansa Biopharma (Sweden)(SE)
Publications by Year
Research Areas
Antifungal resistance and susceptibility, Fungal Infections and Studies, Hematopoietic Stem Cell Transplantation, Pancreatic function and diabetes, Renal Transplantation Outcomes and Treatments
Most-Cited Works
- → Opportunistic Mycelial Fungal Infections in Organ Transplant Recipients: Emerging Importance of Non-Aspergillus Mycelial Fungi(2003)333 cited
- → Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients(1991)281 cited
- → Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients(2003)238 cited
- → Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study1(2003)193 cited
- → LIPOSOMAL AMPHOTERICIN B PREVENTS INVASIVE FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTS(1995)179 cited
- Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.(1993)
- → A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation(2009)139 cited
- → A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT(2008)116 cited
- Transplantation of porcine fetal pancreas to a diabetic patient.(1992)
- Variables predicting deep fungal infections in bone marrow transplant recipients.(1989)